Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Angiotech to spin off part of API division; cancelled

Executive Summary

Angiotech Pharmaceuticals (implantable devices and treatments for acute injuries) will spin off into a new company--Angiotech Pharmaceutical Interventions (API)--its business assets that are outside the IP and royalty revenue related to the Taxus coronary stent system.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Withdrawn
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement
    • Spin-Off

Related Companies